Literature DB >> 8782396

Degradation of olestra, a non caloric fat replacer, by microorganisms isolated from activated sludge and other environments.

D M Lee1, R M Ventullo.   

Abstract

Olestra is a non-caloric fat substitute consisting of fatty acids esterified to sucrose. Previous work has shown that olestra is not metabolized in the gut and is excreted unmodified in human feces. To better understand the fate of olestra in engineered and natural environments, aerobic bacteria and fungi that degrade olestra were enriched from sewage sludges, soils and municipal solid waste compost not previously exposed to olestra. Various mixed and pure cultures were obtained from these sources which were able to utilize olestra as a sole carbon and energy source. The fastest growing enrichment was obtained from activated sludge and later yielded an olestra-degrading pure culture of Pseudomonas aeruginosa. This mixed culture extensively degraded both 14C-fatty acid labeled olestra and 14C-sucrose labeled olestra during 8 days of incubation. Longer-term incubation with pure cultures of P.aeruginosa demonstrated that > 98% of 14C-sucrose labeled olestra and > 72% of 14C-fatty acid labeled olestra was mineralized to CO2 after 69 days. These results indicate that olestra degraders are present in environments not previously exposed to olestra and that olestra can serve as a sole carbon and energy source. Furthermore, a common bacterial species was isolated from activated sludge and shown to have the ability to degrade olestra.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782396     DOI: 10.1007/bf00058185

Source DB:  PubMed          Journal:  Biodegradation        ISSN: 0923-9820            Impact factor:   3.909


  10 in total

1.  Studies on some methane-utilizing bacteria.

Authors:  E R LEADBETTER; J W FOSTER
Journal:  Arch Mikrobiol       Date:  1958

2.  Chronic toxicity and carcinogenicity studies of olestra in Fischer 344 rats.

Authors:  F E Wood; W J Tierney; A L Knezevich; H F Bolte; J K Maurer; R D Bruce
Journal:  Food Chem Toxicol       Date:  1991-04       Impact factor: 6.023

3.  Chronic toxicity and carcinogenicity of olestra in Swiss CD-1 mice.

Authors:  W M Lafranconi; P H Long; J E Atkinson; A L Knezevich; W L Wooding
Journal:  Food Chem Toxicol       Date:  1994-09       Impact factor: 6.023

4.  Microbial transformation of 14C-labeled 2,4,6-trinitrotoluene in an activated-sludge system.

Authors:  D F Carpenter; N G McCormick; J H Cornell; A M Kaplan
Journal:  Appl Environ Microbiol       Date:  1978-05       Impact factor: 4.792

5.  The excretion and characterization of intravenously administered olestra.

Authors:  R J Jandacek; B N Holcombe
Journal:  Lipids       Date:  1991-09       Impact factor: 1.880

6.  A 20-month olestra feeding study in dogs.

Authors:  K W Miller; F E Wood; S B Stuard; C L Alden
Journal:  Food Chem Toxicol       Date:  1991-07       Impact factor: 6.023

7.  Effect of sucrose polyester on fecal bile acid excretion and composition in normal men.

Authors:  C J Glueck; R J Jandacek; M T Subbiah; L Gallon; R Yunker; C Allen; E Hogg; P M Laskarzewski
Journal:  Am J Clin Nutr       Date:  1980-10       Impact factor: 7.045

Review 8.  Safety evaluation of olestra, a nonabsorbed, fatlike fat replacement.

Authors:  C M Bergholz
Journal:  Crit Rev Food Sci Nutr       Date:  1992       Impact factor: 11.176

9.  Disposition of ingested olestra in the Fischer 344 rat.

Authors:  K W Miller; K D Lawson; D H Tallmadge; B L Madison; J R Okenfuss; P Hudson; S Wilson; J Thorstenson; P Vanderploeg
Journal:  Fundam Appl Toxicol       Date:  1995-02

10.  The effect of olestra on breath gas production and faecal microbial counts.

Authors:  M A Eastwood; G S Allgood
Journal:  Eur J Clin Nutr       Date:  1995-09       Impact factor: 4.016

  10 in total
  1 in total

1.  Authors' financial relationships with the food and beverage industry and their published positions on the fat substitute olestra.

Authors:  Jane Levine; Joan Dye Gussow; Diane Hastings; Amy Eccher
Journal:  Am J Public Health       Date:  2003-04       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.